About Servier Pharmaceuticals (India) Private Limited
Data last updated:
Servier Pharmaceuticals (India) Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Serdia Pharmaceuticals India Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 September 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH1998PTC116694.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.7 Lakh. It is led by directors including Pierre Jean Bernard Andriot and Aurelien Breton.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website servier.com.
Company details
Contact details
Servier Pharmaceuticals (India) Private Limited's registered office is in Mumbai, Maharashtra. Its website is servier.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered Address17th Floor Crescenzo Business District B Wing Plot Nos C – 38 & C – 39, G Block Behind Mca BKC Bandra East, Mumbai, Maharashtra, India – 400051
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Servier Pharmaceuticals (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Servier Pharmaceuticals (India) Private Limited
FY 2025 filings availableServier Pharmaceuticals (India) Private Limited reported revenue of ₹6,827 for FY 2022.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹6,827 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Servier Pharmaceuticals (India) Private Limited, buy the company report.
Board of directors of Servier Pharmaceuticals (India) Private Limited
Servier Pharmaceuticals (India) has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bradley Ryan Lloyd Also directs: Servier India Private Limited | Additional Director | 13 Jun 2025 | 1 Years 4 Months | Current |
| Pierre Jean Bernard Andriot Also directs: Servier India Private Limited | Director | 18 Dec 2013 | 12 Years 10 Months | Current |
| Aurelien Breton Also directs: Servier India Private Limited | Director | 23 Sep 2024 | 2 Years 1 Months | Current |
Auditor
Servier Pharmaceuticals (India) Private Limited is audited by Y S MOOCHHALA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Y S MOOCHHALA & CO | FY 2020 | 124848W |
Shareholding
The shareholding of Servier Pharmaceuticals (India) Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Servier Pharmaceuticals (India) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Servier Pharmaceuticals (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Servier Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Servier Pharmaceuticals (India) Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Servier Pharmaceuticals (India) Private Limited has 13 board changes on record since 2013: 4 appointments and 9 cessations. The latest: Bradley Ryan Lloyd was appointed as Additional Director on 13 Jun 2025.
4 earlier events are in the company report.
News
Frequently asked questions
Servier Pharmaceuticals (India) is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 September 1998 (28+ years old) and is registered under CIN U51397MH1998PTC116694.
Servier Pharmaceuticals (India) has 3 current directors:
- Bradley Ryan Lloyd - Additional Director
- Pierre Jean Bernard Andriot - Director
- Aurelien Breton - Director
The latest financial statements of Servier Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Servier Pharmaceuticals (India) is U51397MH1998PTC116694. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Servier Pharmaceuticals (India) was incorporated on 28 September 1998, making it 28+ years old. It is registered with the Registrar of Companies, Mumbai.
Bradley Ryan Lloyd was appointed as Additional Director on 13 Jun 2025. Aurelien Breton ceased to be Additional Director on 29 Sep 2024. Aurelien Breton was appointed as Director on 23 Sep 2024. Servier Pharmaceuticals (India) has 13 board changes on record in total.
Servier Pharmaceuticals (India) can be reached through the website servier.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Servier Pharmaceuticals (India) is at 17th Floor Crescenzo Business District B Wing Plot Nos C – 38 & C – 39, G Block Behind Mca BKC Bandra East, Mumbai, Maharashtra, India – 400051.
Servier Pharmaceuticals (India) operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Servier Pharmaceuticals (India) is compliant as of 10 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
